+ An innovative approach to studying Huntington’s Disease Caroline Fukawa Dr. McElwain, PhD.

Slides:

Advertisements

Similar presentations

 Dominant neurodegenerative disease  Polyglutamine repeat expansions (CAG, codon, Q) in exon 1 of huntingtin gene (htt). Usually >35 CAG repeats. 

Advertisements

Experimental pathology refers to the observation of the effects of manipulations on animal models or cell cultures regarding researches on human diseases.

Drosophila melanogaster Staining Lab Matthew Lee Keenan Mahan.

Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter

Huntington’s Disease. Huntington's Disease is an autosomal dominant genetic disorder Meaning that if a parent has Huntington's there is a 50% chance the.

Stem Cells and Regenerative Medicine

THE MUSCULAR SYSTEM By: Alec Melville and Casey Kahn.

Gene therapy for eye disease UCL Institute of Ophthalmology Department of Genetics An experimental technique that uses the delivery of genetic material.

Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.

What is Huntington’s disease? It is a progressive degeneration of the nerve cells in the brain. This disease cause uncontrolled movements, emotional problems,

Huntington’s Disease Michael Ou Pierce Lam.

A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.

FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.

Mendelian inheritance has its physical basis in the behavior of chromosomes Chapter 15, Section 1.

Neural Progenitor Cells as Replacement Therapy for Diseased and Aging Brains. R.G. Jarman, E. Alveraz, C.R. Freed; Division of Clinical Pharmacology, Dept.

KEY CONCEPT Science is a way of thinking, questioning, and gathering evidence.

Sex Ratio in Humans: In the early 1900’s Thomas Hunt Morgan began breeding a type of fruit fly called Drosophila melanogaster.

FMRI guided Microarray analysis Imaging-Guided Microarray: Isolating Molecular Profiles That Dissociate Alzheimer’s Disease from Normal Aging  A.C. Pereira,

Present and Future Treatments for Retinal Degenerative Diseases: An Overview Gerald J. Chader Doheny Retina Institute USC Medical School Los Angeles, CA.

Do you remember what you ate for dinner two days ago?

Genetic Counselling L.O: to explain the role of a genetic counsellor Starter: What sources of information might a genetic counsellor use when examining.

By: Jack Wernet.  “A gene on one of the non-sex chromosomes that is always expressed, even if only one copy is present.” (Human Genome Project Information.

1.3 Scientific Thinking and Processes KEY CONCEPT Science is a way of thinking, questioning, and gathering evidence.

47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.

The effects of Malathion and the comparison to the NTE1 gene in yeast Ashley Swift Mentor: David Singleton Introduction : Malathion is a widely used organophosphorous.

Identifying Genes that Control Wing Shape in Flies Gregory Campbell Central Catholic High School Pittsburgh.

The Chromosomal Basis of Inheritance. Chromosomal Theory of Inheritance Genes are physically located at loci on chromosomes Additionally, it is chromosomes.

HUNTINGTON’S DISEASE MAGGIE PHOEBE LEONORA BY:. NAME OF DISORDER? ARE THERE OTHER NAMES FOR DISORDER/DISEASE (WHAT ARE THEY)? Huntington's disease -first.

By Katelyn Chaimson and Sean Guyot

Using Stem Cells to Treat Ailments of the Nervous System Crista Chavez, Jacqueline Doody, Nina Roxo, Aleksandra Sabov & Zachary Taylor Faculty Mentor:

Clinical Features Huntington’s disease is a rapidly progressive neurodegenerative disease that leads to dementia. Typically presents with alterations.

DAY 2 Unit 3 Inheritance and Molecular Genetics 1.

Hannah Beacom and Thomas Bennett Pd. 3.  Rare inherited disorder  Caused by genetic stutter  Progressive loss of nerve cells in brain  Results in.

Wang Chung Han. INTRODUCTION Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder resulting from a CAG expansion in the huntingtin.

HUNTINGTON’S DISEASE Neil Madadi. WHAT IS HUNTINGTON’S DISEASE?  It is an autosomal dominant inherited disease. Meaning that only one copy of the altered.

STEM CELL RESEARCH ON HUNTINGTON’S DISEASE Josh Merrifield, Michael Jennings, and Stephanie Antone.

Genetic Disorders Research Project

Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged.

Huntington’s Disease BY: SAM DAVIS, SABRINA TRAN, MYA LUNA, MYLES BLACKWELL AND EAMONN DUENSING.

 Only caused by: › Inherited genetic defect › Mutation  Defect or mutation is a CAG repeat in the HD gene of chromosome 4  CAG repeat  abnormal Huntingtin.

Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.

Dupilumab With Topical Corticosteroids Superior To Treatment With TCS Paris, France, and Tarrytown, N.Y., – June 6, 2016 – Sanofi and Regeneron “outed”

Genetic Diversity Sorting &recombination of genes in sexual reproduction results in a great variety of gene combinations in the offspring.Do you look EXACTLY.

What are Mutations? Why and How are they Studies?

Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease C Bjartmar, J.R Wujek, B.D Trapp Journal of.

(Draw and label a picture of a neurone here)

Huntington’s Disease.

Agustina Setiawati, M.Sc., Apt

“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.

EXAMPLES OF TECHNOLOGIES USED IN BIOLOGY

Nervous System: Medical Conditions

Huntington’s Disease Julia Elder.

KEY CONCEPT Technology continually changes the way biologists work.

Altered biological activity of peroxynitrite-modified nerve growth factor (NGF) compared to native NGF in vitro. A: Dorsal root ganglia (DRG) neurons that.

Objectives Methods Results Conclusion

Drosophila in the Study of Neurodegenerative Disease

Glucose Transporter Type I Deficiency (G1D) at 25 ( ): Presumptions, Facts, and the Lives of Persons With This Rare Disease Juan M. Pascual,

COMPLEX PATTERNS OF INHERITANCE

Volume 2, Issue 6, Pages (June 2002)

Steve S.W. Han, Luis A. Williams, Kevin C. Eggan Neuron

Huntingtons Disease early symptoms include cognitive dysfunction, memory problems, depression, clumsiness or motor incoordination first described syndrome.

FUNCTIONS OF THE BASAL NUCLEI FUNCTIONS OF THE BASAL NUCLEI assist in the regulation of voluntary movement & the learning of motor skills initiate movement.

Volume 40, Issue 1, Pages (September 2003)

Volume 90, Issue 3, Pages (May 2016)

Mouse and Drosophila models of AD

Folic acid increases apical junctional pMLCK localization in vivo

Small molecule suppression of ATXN3-CAG89 aggregation.

Volume 15, Issue 5, Pages (May 2007)

Presentation transcript:

+ An innovative approach to studying Huntington’s Disease Caroline Fukawa Dr. McElwain, PhD

+ Huntington’s Disease Neurodegenerative disorder Results in the involuntary movements of the body and lack of cognitive control

+ Drosophila melanogaster Fruit Flies Why they are useful for studying Huntington’s Disease Figure 1. Cross sections through a normal and postmortem HD patient demonstrate dramatic degeneration. Cross-sections through the eye of the eye of fly expressing a protein similar to the huntingtin transgene show similar loss of neuronal tissue.

+ Previous Studies Used the Drosophila model to study Huntington’s disease and have found there is degeneration in the phenotype of the fly (Marsh 2003) Studies use the whole organism, in-vivo, which is both costly and not time efficient Belgian scientists- discovered away to study brains of Drosophila in-vitro (Moseman 2008) Combination of these studies leads to my research question

+ My Research Question Is it possible to study Huntington’s Disease in-vitro in the Drosophila model? Extract the brains from the Drosophila and see if they exhibit the same phenotype that they did in the in-vivo studies Make a comparison of 4 different brains: 2 control and 2 experimental 2 control: One Wild type brain and One Huntington’s Brain 2 experimental: Wild type brain treated with methylene blue and a Huntington’s brain treated with methylene blue Methylene blue has been proven to reduce the number of protein aggregates of the Huntingtin protein (in-vivo) Use immunofluorescent staining and a standard fluorescent microscope

+ Wild Type Brain (No degeneration) Expected Results Huntington’s Brain (Significant degeneration) Wild Type Brain treated with Methylene Blue (No change) Huntington’s Brain treated with Methylene Blue (Decrease in degeneration) *The colored lines are representative of the amount of degeneration that occurs

+ Expected Results Cont’d Expected Results- similar to the in-vivo studies; reduction of aggregates Advantages- more cost effective, test possible cures/treatments for the disease faster and more readily Figure 2: Immunofluorescent staining in Drosophila brains

+ Works Cited Egger, Boris, Lena Van Giesen, Manuela Moraru, and Simon G Sprecher. "In Vitro Imaging of Primary Neural Cell Culture from Drosophila." Nat Protoc Nature Protocols (2013): "Huntington Disease." Genetics Home Reference. 1 June Web. 27 Oct "Huntington's Disease." Mayo Clinic. Mayo Clinic, 14 July Web. 26 Oct "Nearly 1 in 6 of World's Population Suffer from Neurological Disorders – UN Report." UN News Center. UN, 27 Feb Web. 28 Oct Marsh, J. L., J. Pallos, and L. M. Thompson. "Fly Models of Huntington's Disease." Human Molecular Genetics (2003). Moseman, Andrew. "Fruit Fly Brains Stay Alive in a Dish, Teach Us About Nerve Damage - Discoblog." Discover: Science for the Curious. Kalmbach Publishing Company, 5 June Web. 10 Oct a Sontag, E. M., G. P. Lotz, N. Agrawal, A. Tran, R. Aron, G. Yang, M. Necula, A. Lau, S. Finkbeiner, C. Glabe, J. L. Marsh, P. J. Muchowski, and L. M. Thompson. "Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models." Journal of Neuroscience (2012):